Effects of finasteride on vascular endothelial growth factor - A placebo-controlled randomized study in BPH patients

Scandinavian Journal of Urology and Nephrology

Volumn 36, Issue 3, 2002, Pages 182-187

  Haggstrom S ^a   Torring N ^b   Moller K ^b   Jensen, E ^b   Lund, L ^b   Nielsen, J E ^b   Bergh, A ^a   Damber, J E ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benign prostatic hyperplasia (BPH); Finasteride; Placebo control; VEGF

Indexed keywords

FINASTERIDE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLEEDING; CASTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN TISSUE; MALE; ORGAN GROWTH; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION; WESTERN BLOTTING;

BLOTTING, WESTERN; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FINASTERIDE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MICROCIRCULATION; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; TESTOSTERONE 5-ALPHA-REDUCTASE; TRANSURETHRAL RESECTION OF PROSTATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18444372935     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655902320131848     Document Type: Article

References (34)

1. Quality-of-life aspects in urology - Benign prostatic hyperplasia
2. Benign prostatic hyperplasia: Pathophysiology and pharmacological treatment
3. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
4. Treatment of prostatic bleeding: Suppression of angiogenesis by androgen deprivation
5. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: A preliminary report
6. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration
7. Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival
8. Early effects of castration on the vascular system of the rat ventral prostate gland
9. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration
10. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats
11. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers
12. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
13. Benign prostatic hyperplasia. Medical and minimally invasive treatment options
14. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
15. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia
16. Microvascular anatomy in patients with recurrent haeumaturia related to prostatic hypertrophy
17. Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia
18. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride
19. Effects of finasteride and bicalutamide on prostate blood flow in the rat
20. Finasteride inhibits angiogenesis and expression of VEGF in human BPH
21. Vascular density is a predictor of cancer-specific survival in prostate carcinoma
22. Angiogenic peptide in prostatic disease
23. Vascular endothelial growth factor content in metastasising and non metastasising Dunning prostatic adenocarcinoma
24. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens
25. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats
26. Is tissue mass regulated by vascular endothelial cells?. Prostate as the first evidence
27. Effects of finasteride on microvessel density (MVD) in patients wiht recurrent haematuria related to prosatic hypertrophy (BPH)
28. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
29. The treatment of gross hematuria secondary to prostatic bleeding with finasteride
30. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: Long-term follow-up
31. Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostate
32. Hemodynamic effects of intracoronary VEGF delivery: Evidence of tachyphylaxis and NO dependence of response
33. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotention
34. Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity